Amatya Sajeen Bahadur, Salmi Sonja, Kainulainen Veera, Karihtala Peeter, Reunanen Justus
Biocenter Oulu & Cancer and Translational Medicine Research Unit, University of Oulu, 90014 Oulu, Finland.
Human Microbiome Research Program Unit, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
Cancers (Basel). 2021 Oct 29;13(21):5450. doi: 10.3390/cancers13215450.
Bacterial extracellular vesicles are membrane-enclosed, lipid bi-layer nanostructures that carry different classes of biomolecules, such as nucleic acids, lipids, proteins, and diverse types of small molecular metabolites, as their cargo. Almost all of the bacteria in the gut secrete extracellular vesicles to assist them in competition, survival, material exchange, host immune modulation, infection, and invasion. The role of gut microbiota in the development, progression, and pathogenesis of gastrointestinal tract (GIT) cancer has been well documented. However, the possible involvement of bacterial extracellular vesicles (bEVs) in GIT cancer pathophysiology has not been given due attention. Studies have illustrated the ability of bEVs to cross physiological barriers, selectively accumulate near tumor cells, and possibly alter the tumor microenvironment (TME). A systematic search of original published works related to bacterial extracellular vesicles on gastrointestinal cancer was performed for this review. The current systemic review outlines the possible impact of gut microbiota derived bEVs in GIT cancer in light of present-day understanding. The necessity of using advanced sequencing technologies, such as genetic, proteomic, and metabolomic investigation methodologies, to facilitate an understanding of the interrelationship between cancer-associated bacterial vesicles and gastrointestinal cancer is also emphasized. We further discuss the clinical and pharmaceutical potential of bEVs, along with future efforts needed to understand the mechanism of interaction of bEVs in GIT cancer pathogenesis.
细菌细胞外囊泡是膜包裹的脂质双层纳米结构,其携带不同种类的生物分子,如核酸、脂质、蛋白质以及各种类型的小分子代谢产物作为其货物。肠道中几乎所有细菌都会分泌细胞外囊泡,以帮助它们进行竞争、生存、物质交换、调节宿主免疫、感染和侵袭。肠道微生物群在胃肠道(GIT)癌症的发生、发展和发病机制中的作用已有充分记载。然而,细菌细胞外囊泡(bEVs)在GIT癌症病理生理学中的可能作用尚未得到应有的关注。研究表明,bEVs能够穿过生理屏障,选择性地在肿瘤细胞附近积聚,并可能改变肿瘤微环境(TME)。本综述对已发表的有关胃肠道癌症中细菌细胞外囊泡的原始研究进行了系统检索。根据目前的认识,本系统性综述概述了肠道微生物群衍生的bEVs在GIT癌症中的可能影响。还强调了使用先进的测序技术,如基因、蛋白质组学和代谢组学研究方法,以促进对癌症相关细菌囊泡与胃肠道癌症之间相互关系理解的必要性。我们进一步讨论了bEVs的临床和制药潜力,以及未来了解bEVs在GIT癌症发病机制中相互作用机制所需的努力。